Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-01-31
2009-06-16
Aulakh, Charanjit S (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S285000
Reexamination Certificate
active
07547714
ABSTRACT:
The present invention is directed to compounds of Formula I:or salt thereof, which are modulators of the glucocorticoid receptor. The compounds and salts of the invention are useful in the treatment of conditions mediated by glucocorticoid receptor activity.
REFERENCES:
patent: 6106864 (2000-08-01), Dolan et al.
patent: 6380223 (2002-04-01), Dow et al.
patent: 7138406 (2006-11-01), Chantigny et al.
patent: 2002/0107235 (2002-08-01), Liu et al.
patent: 2004/0014741 (2004-01-01), Liu et al.
patent: 2004/0176595 (2004-09-01), Dow et al.
patent: 2006/0247264 (2006-11-01), Chantigny et al.
patent: 2008/0188443 (2008-08-01), Cheng et al.
patent: 0 188 396 (1986-07-01), None
patent: 1 201 649 (2001-05-01), None
patent: 1 201 655 (2002-05-01), None
patent: WO 98/31702 (2000-11-01), None
patent: WO01/05229 (2001-01-01), None
patent: WO03/000226 (2003-01-01), None
patent: WO03/020216 (2003-03-01), None
patent: WO03/063833 (2003-08-01), None
patent: WO00/66522 (2004-01-01), None
patent: WO2004/004653 (2004-01-01), None
patent: WO2004005229 (2004-01-01), None
patent: WO2004041214 (2004-05-01), None
patent: WO2004041215 (2004-05-01), None
patent: WO2004/069202 (2004-08-01), None
patent: WO2005/009382 (2005-02-01), None
patent: WO2005/009388 (2005-02-01), None
patent: WO2005/047254 (2005-05-01), None
patent: WO2007131041 (2007-11-01), None
Adcock, et al.; 2006; New Insights into the Molecular Mechanisms of Corticosteroids Actions; Current Drug Targets; 7; 649-660.
Buttgereit, et al.; 2005; Optimised glucocorticoid therapy: the sharpening of an old spear; Lancet; 365; 801-803.
Catley; 2007; Dissociated Steroids; The Scientific World; 7; 421-430.
Chemical Abstracts; 1976; 84(19).
Finin & Morgan; 1999;Transdermal Penetration Enhancers:Applications, Limitations, and Potential; Journal of Pharmaceutical Science; 88(10); 955-958.
Liang & Chen; 2001; Fast-dissolving intraoral drug delivery systems; Expert Opinion in Therapeutic Patents; 11(6); 981-986.
Miner, et al.;2005; New and improved glucocorticoid receptor ligands; Expert Opinion In Investigative Drugs; 14(12); 1527-1545.
Mohler, et al.; 2007; Dissociated non-steroidal glucocorticoids: tuning out untoward effects; Expert Opinion on Investigative Drugs; 17(1); 37-58.
Morgan, et al.;2004;Discovery of potent, Non-Steroidal and Highly Selective Glucocorticoid Receptor Antagonists w/Anti-Obesity Activity;Letters in Drug Design & Discovery;1;1-5.
Morgan,et al.;2002;Discovery of potent, Non-Steroidal and Highly Selective Glucocorticoid Receptor Antagonists w/Anti-Obesity Activity; J. of Med. Chem; 45;2417-2424.
Verma, et al.; 2001; Current Status of Drug Delivery Technologies and Future Directions;:Pharmaceutical Technology On-Line;25(2);1-14.
Preliminary Amendment filed Feb. 19, 2002 in U.S. Appl. No. 10/080,174.
Aulakh Charanjit S
Boss Brandon S.
Pfizer Inc.
Polster Philip B.
LandOfFree
Tricyclic compounds, compositions, and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tricyclic compounds, compositions, and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic compounds, compositions, and methods will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4082866